Trials / Completed
CompletedNCT04304287
The Benefit of Autologous Blood Transfusion in Total Hip Arthroplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Clinical Hospital Centre Zagreb · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators studied the benefit of preoperative autologous blood donation in participants who undergo total hip arthroplasty. Study is made as a prospective and randomized.
Detailed description
Total hip arthroplasty is procedure followed with large perioperative and postoperative blood loss. In order to avoid the application of large amounts of allogeneic blood, preoperative autologous blood donation as a tipe of autologous transfusion have been developed. In this study, the investigators studied the benefit of preoperative autologous blood donation in participants who undergo total hip arthroplasty. Study is made as a prospective and randomized. Participants were divided into three groups: the first group donated one dose of autologous blood 14 days preoperatively, the second group donated one dose of autologous blood 72 hours preoperatively and a third group was not donated autologous blood. The blood parameters, hemodynamic stability, bleeding, the need for application of autologous or homologous blood and length of hospital stay were compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Preoperative autologous blood donation, 14 days before surgery | |
| PROCEDURE | Preoperative autologous blood donation, 72 hours before surgery | |
| PROCEDURE | Without preoperative blood donation |
Timeline
- Start date
- 2011-01-16
- Primary completion
- 2013-06-15
- Completion
- 2015-06-15
- First posted
- 2020-03-11
- Last updated
- 2020-03-23
Source: ClinicalTrials.gov record NCT04304287. Inclusion in this directory is not an endorsement.